The OxVALVE study is based in Oxfordshire in the UK. Our study has two aims: firstly, to identify people with Valvular Heart Disease and hence to establish its incidence within the population. Secondly, by further investigation we hope to develop improved treatment strategies for Valvular Heart Disease.
Survival of people with valvular heart disease in a large, English community-based cohort study
TAYLOR C. et al, (2021), Heart
Community prevalence, mechanisms and outcome of mitral or tricuspid regurgitation.
Cahill TJ. et al, (2021), Heart
CMR in Evaluating Valvular Heart Disease: Diagnosis, Severity, and Outcomes.
Myerson SG., (2020), JACC Cardiovasc Imaging
Cardiac auscultation poorly predicts the presence of valvular heart disease in asymptomatic primary care patients.
Gardezi SKM. et al, (2018), Heart, 104, 1832 - 1835
The predictors and risk factors of atrial fibrillation in a population cohort and its association with valvular heart disease
Gardezi SKM. et al, (2018), EUROPEAN HEART JOURNAL, 39, 918 - 919
Cardiac auscultation in diagnosing valvular heart disease: a comparison between general practitioners and cardiologists
Gardezi SKM. et al, (2017), EUROPEAN HEART JOURNAL, 38, 1155 - 1155
The OxVALVE Study
Cardiac Investigations Annexe
John Radcliffe Hospital
Oxford OX3 9DU
Tel: (01865) 228927
Fax (01865) 228989